Labetalol Versus Methyldopa: Comparison of Frequency of Small for Gestational Age in the Treatment of Pregnancy Induced Hypertension

Background: To compare the frequency of small for gestational age(SGA) babies between women treated with labetalol or methyldopa for pregnancy induced hypertension. Methods: In this randomized controlled trial patients were divided into Labetalol and Methyldopa groups. Both drugs were administered a...

Full description

Bibliographic Details
Main Authors: Shabana Kalsoom, Noreen Majeed, Mamoona Riaz, Shamsa Tariq
Format: Article
Language:English
Published: Rawalpindi Medical University 2018-12-01
Series:Journal of Rawalpindi Medical College
Subjects:
Online Access:https://www.journalrmc.com/index.php/JRMC/article/view/962
_version_ 1818644286663557120
author Shabana Kalsoom
Noreen Majeed
Mamoona Riaz
Shamsa Tariq
author_facet Shabana Kalsoom
Noreen Majeed
Mamoona Riaz
Shamsa Tariq
author_sort Shabana Kalsoom
collection DOAJ
description Background: To compare the frequency of small for gestational age(SGA) babies between women treated with labetalol or methyldopa for pregnancy induced hypertension. Methods: In this randomized controlled trial patients were divided into Labetalol and Methyldopa groups. Both drugs were administered as oral preparation. Patients were followed during their pregnancy till their delivery time and then baby weight was checked at the time of delivery and plotted against gestational age to detect small for gestational age babies. Results: The frequency of SGA neonates was significantly higher in Group-A (labetalol) in comparison to Group-B. (Methyldopa) i.e. Group-A: 37.8% vs. Group-B 13.3%(p-value=0.008). In all age groups i.e. <25years, 25-35years and >35 years, frequency of SGA was higher in Group-A (Labetalol group) women but statistical significance was not seen in any age group. There was no statistically significant effect of parity on frequency of SGA. Women who were started treatment early i-e at 20-25weeks and 26-30weeks of gestation had more SGA babies in Labetalol group(p=0.033,P=0.032) . Although more number of SGA babies in Labetalol group were delivered at <34 weeks gestation but difference was not statistically significant (p=0.264) Conclusion: Methyldopa is more effective in pregnant women in terms of low incidence of small for gestational age babies as compared to labetalol.
first_indexed 2024-12-17T00:12:26Z
format Article
id doaj.art-343a40342cbe4a4e86a9e084f481d02a
institution Directory Open Access Journal
issn 1683-3562
1683-3570
language English
last_indexed 2024-12-17T00:12:26Z
publishDate 2018-12-01
publisher Rawalpindi Medical University
record_format Article
series Journal of Rawalpindi Medical College
spelling doaj.art-343a40342cbe4a4e86a9e084f481d02a2022-12-21T22:10:47ZengRawalpindi Medical UniversityJournal of Rawalpindi Medical College1683-35621683-35702018-12-01Labetalol Versus Methyldopa: Comparison of Frequency of Small for Gestational Age in the Treatment of Pregnancy Induced HypertensionShabana Kalsoom0Noreen Majeed1Mamoona Riaz2Shamsa Tariq3Department of Gynaecology and Obstetrics, Wah Medical College, Wah Cantt.Department of Gynaecology and Obstetrics, Wah Medical College, Wah CanttDepartment of Gynaecology and Obstetrics, Wah Medical College, Wah CanttDepartment of Gynaecology and Obstetrics, Wah Medical College, Wah Cantt.Background: To compare the frequency of small for gestational age(SGA) babies between women treated with labetalol or methyldopa for pregnancy induced hypertension. Methods: In this randomized controlled trial patients were divided into Labetalol and Methyldopa groups. Both drugs were administered as oral preparation. Patients were followed during their pregnancy till their delivery time and then baby weight was checked at the time of delivery and plotted against gestational age to detect small for gestational age babies. Results: The frequency of SGA neonates was significantly higher in Group-A (labetalol) in comparison to Group-B. (Methyldopa) i.e. Group-A: 37.8% vs. Group-B 13.3%(p-value=0.008). In all age groups i.e. <25years, 25-35years and >35 years, frequency of SGA was higher in Group-A (Labetalol group) women but statistical significance was not seen in any age group. There was no statistically significant effect of parity on frequency of SGA. Women who were started treatment early i-e at 20-25weeks and 26-30weeks of gestation had more SGA babies in Labetalol group(p=0.033,P=0.032) . Although more number of SGA babies in Labetalol group were delivered at <34 weeks gestation but difference was not statistically significant (p=0.264) Conclusion: Methyldopa is more effective in pregnant women in terms of low incidence of small for gestational age babies as compared to labetalol.https://www.journalrmc.com/index.php/JRMC/article/view/962Small for gestational age babiesLabetalolMethyldopaPregnancy induced hypertension
spellingShingle Shabana Kalsoom
Noreen Majeed
Mamoona Riaz
Shamsa Tariq
Labetalol Versus Methyldopa: Comparison of Frequency of Small for Gestational Age in the Treatment of Pregnancy Induced Hypertension
Journal of Rawalpindi Medical College
Small for gestational age babies
Labetalol
Methyldopa
Pregnancy induced hypertension
title Labetalol Versus Methyldopa: Comparison of Frequency of Small for Gestational Age in the Treatment of Pregnancy Induced Hypertension
title_full Labetalol Versus Methyldopa: Comparison of Frequency of Small for Gestational Age in the Treatment of Pregnancy Induced Hypertension
title_fullStr Labetalol Versus Methyldopa: Comparison of Frequency of Small for Gestational Age in the Treatment of Pregnancy Induced Hypertension
title_full_unstemmed Labetalol Versus Methyldopa: Comparison of Frequency of Small for Gestational Age in the Treatment of Pregnancy Induced Hypertension
title_short Labetalol Versus Methyldopa: Comparison of Frequency of Small for Gestational Age in the Treatment of Pregnancy Induced Hypertension
title_sort labetalol versus methyldopa comparison of frequency of small for gestational age in the treatment of pregnancy induced hypertension
topic Small for gestational age babies
Labetalol
Methyldopa
Pregnancy induced hypertension
url https://www.journalrmc.com/index.php/JRMC/article/view/962
work_keys_str_mv AT shabanakalsoom labetalolversusmethyldopacomparisonoffrequencyofsmallforgestationalageinthetreatmentofpregnancyinducedhypertension
AT noreenmajeed labetalolversusmethyldopacomparisonoffrequencyofsmallforgestationalageinthetreatmentofpregnancyinducedhypertension
AT mamoonariaz labetalolversusmethyldopacomparisonoffrequencyofsmallforgestationalageinthetreatmentofpregnancyinducedhypertension
AT shamsatariq labetalolversusmethyldopacomparisonoffrequencyofsmallforgestationalageinthetreatmentofpregnancyinducedhypertension